Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sinol Australia is the official distributor of Sinol USA's all-natural, capsaicin-based over-the-counter (OTC) nasal sprays in Australia, New Zealand, and parts of the Asia-Pacific region. The company's product line includes Sinol-M Fast Headache Relief, Sinol-M Fast Allergy & Sinus Relief, Sinol-D Decongestant, and Viral Defense and Nasal Wash. These products utilize capsaicin (derived from the pepper plant) to desensitize nasal mucous membranes, dilate constricted blood vessels, and reduce Substance P to relieve headaches, migraines, sinusitis, and allergies. Enriched with natural ingredients like aloe vera, eucalyptus oil, rosemary extract, and patented nano-silver, Sinol's formulations provide rapid relief without the rebound effects or drowsiness associated with traditional nasal sprays.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sinol Australia.